(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.34%) $0.927
(0.79%) $10.85
(0.10%) $0.792
(0.13%) $92.56
4 days till quarter result
(bmo 2024-04-01)
Expected move: +/- 7.97%
Live Chart Being Loaded With Signals
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy...
Stats | |
---|---|
Today's Volume | 31 245.00 |
Average Volume | 102 339 |
Market Cap | 1.84M |
EPS | $-0.420 ( 2023-11-13 ) |
Next earnings date | ( $0 ) 2024-04-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.290 |
ATR14 | $0.0160 (1.78%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-23 | Mika Thomas | Buy | 16 666 | Option to Purchase Common Stock |
2024-01-23 | Jacob Harold | Buy | 6 667 | Option to Purchase Common Stock |
2024-01-23 | Schroeder Maria | Buy | 16 667 | Option to Purchase Common Stock |
2024-01-23 | Ferguson Michael | Buy | 16 666 | Option to Purchase Common Stock |
2024-01-23 | Goldstein Martin M | Buy | 16 667 | Option to Purchase Common Stock |
INSIDER POWER |
---|
29.89 |
Last 97 transactions |
Buy: 2 103 083 | Sell: 846 526 |
Volume Correlation
Nanovibronix Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nanovibronix Inc Correlation - Currency/Commodity
Nanovibronix Inc Financials
Annual | 2022 |
Revenue: | $752 000 |
Gross Profit: | $167 000 (22.21 %) |
EPS: | $-3.84 |
Q3 | 2023 |
Revenue: | $458 000 |
Gross Profit: | $349 000 (76.20 %) |
EPS: | $-0.420 |
Q2 | 2023 |
Revenue: | $294 000 |
Gross Profit: | $216 000 (73.47 %) |
EPS: | $-0.650 |
Q1 | 2023 |
Revenue: | $354 000 |
Gross Profit: | $235 000 (66.38 %) |
EPS: | $-0.660 |
Financial Reports:
No articles found.
Nanovibronix Inc
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators